Lataa...

Timing of multikinase inhibitor initiation in differentiated thyroid cancer

There are limited treatment options for patients with radioactive iodine refractory, progressive differentiated thyroid cancer. Although there is consensus that multikinase inhibitor therapy should be considered in patients with progressive disease with considerable tumor load or symptomatic disease...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Endocr Relat Cancer
Päätekijät: Brose, Marcia S, Smit, Johannes, Lin, Chia-Chi, Pitoia, Fabian, Fellous, Marc, DeSanctis, Yoriko, Schlumberger, Martin, Tori, Masayuki, Sugitani, Iwao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Bioscientifica Ltd 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446590/
https://ncbi.nlm.nih.gov/pubmed/28270435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0016
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!